New Zealand-based The A2 Milk Company has successfully finalized a $282 million acquisition of Yashili New Zealand’s Pokeno nutritional manufacturing facility. The deal was made with China’s Mengniu Dairy Group.
With this acquisition, The A2 Milk Company now wholly owns the integrated plant. The facility was previously responsible for producing two China label infant milk formula products. Now under new ownership, the company plans to rebrand these products under the A2 Milk brand. This revamp is predicted to be completed within a year and a half, pending necessary regulatory approval.
Pip Greenwood, the chairperson of The A2 Milk Company, shared that this purchase ensures greater certainty regarding the company’s capital needs. In addition to this, the acquisition will pave the way towards delivering increased value to the company’s shareholders. It is intended that this will be facilitated through a proposed special dividend of $300 million.
Further benefits of owning the Pokeno facility include the potential for a third registration slot. Recognized as a significant producer of A2 Milk’s English label products, the facility is expected to play an essential role in the company’s expansion plans within the Chinese market.
David Bortolussi, managing director and CEO, praised the Pokeno facility for its globally respected reputation. He highlighted its consistent production of high-quality infant milk formula, including their English label products, A2 Gentle Gold and A2 Genesis.
What is the scope of the acquisition of The A2 Milk Company?
The A2 Milk Company has acquired full ownership of Yashili New Zealand’s Pokeno nutritional manufacturing facility in a $282 million deal with China’s Mengniu Dairy Group.
What are the future plans for the products of the Pokeno facility?
The company plans to rebrand the two China label infant milk formula products produced at the Pokeno facility under the A2 Milk brand, subject to regulatory approval.
How will the acquisition contribute to shareholders’ value?
The acquisition is expected to provide more certainty regarding the company’s capital needs. It will also potentially return value to shareholders through a planned special dividend of $300 million.
